DAPT Maintains Early Neurologic Function in Mild-Moderate Stroke
(MedPage Today) -- In certain patients with mild-to-moderate acute ischemic stroke, dual antiplatelet therapy (DAPT) with aspirin and clopidogrel (Plavix) reduced early neurologic deterioration better than aspirin alone, the Chinese randomized... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 13, 2024 Category: Cardiology Source Type: news

Most Disadvantaged Least Likely to Receive Thrombolysis Most Disadvantaged Least Likely to Receive Thrombolysis
Black, male, and older ischemic stroke patients are less likely than other populations to antithrombolytic therapy.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 8, 2024 Category: Neurology Tags: Neurology & Neurosurgery Source Type: news

Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care
KARDIA-2 study met its primary endpoint, demonstrating clinically significant systolic blood pressure reductions in each treatment arm at month threeZilebesiran added to a standard of care hypertension medication demonstrated an encouraging safety and tolerability profile in adults with mild to moderate uncontrolled hypertension, and results support the potential for twice-yearly dosingRoche and Alnylam have initiated the Phase II KARDIA-3 study in adults with uncontrolled hypertension at high cardiovascular riskKARDIA-2 study results will be presented as a late-breaking abstract in April at the 2024 American College of Ca...
Source: Roche Investor Update - March 5, 2024 Category: Pharmaceuticals Source Type: news

Roche and Alnylam report positive topline results from the Phase II KARDIA-2 study in people with hypertension, demonstrating clinically significant blood pressure reductions with zilebesiran when added to standard of care
KARDIA-2 study met its primary endpoint, demonstrating clinically significant systolic blood pressure reductions in each treatment arm at month threeZilebesiran added to a standard of care hypertension medication demonstrated an encouraging safety and tolerability profile in adults with mild to moderate uncontrolled hypertension, and results support the potential for twice-yearly dosingRoche and Alnylam have initiated the Phase II KARDIA-3 study in adults with uncontrolled hypertension at high cardiovascular riskKARDIA-2 study results will be presented as a late-breaking abstract in April at the 2024 American College of Ca...
Source: Roche Media News - March 5, 2024 Category: Pharmaceuticals Source Type: news

Hourly Heat Exposure Linked to Increased Risk for Acute Ischemic Stroke
THURSDAY, Feb. 29, 2024 -- Hourly heat exposure is associated with an increased risk for acute ischemic stroke (AIS) onset, according to a study published online Feb. 28 in JAMA Network Open. Xinlei Zhu, from Fudan University in Shanghai, and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 29, 2024 Category: Pharmaceuticals Source Type: news

Anti-cancer drug could improve symptoms after stroke
A study by the Institut de Neurociències of the UAB (INc-UAB) demonstrates in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain injuries and help in restoring brain tissue. Ischemic stroke is the second leading cause of death worldwide and occurs when blood flow cannot reach the brain due to an obstruction. (Source: World Pharma News)
Source: World Pharma News - February 28, 2024 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Thrombectomy Benefits Large Core Stroke Out to 1 Year Thrombectomy Benefits Large Core Stroke Out to 1 Year
New results from the SELECT2 trial also show benefit of the procedure in a large range of ischemic core sizes and in patients transferred from an outside hospital.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 22, 2024 Category: Cardiology Tags: Cardiology Source Type: news

Deep-learning accelerated brain MRI improves stroke lesion detection
Deep learning-accelerated brain MRI improves the detection of acute ischemic lesions compared to conventional MRI because it offers better image quality and significantly decreased exam times, researchers have reported in a study published in Radiology.The technique could translate to better patient care in that it could improve imaging workflow and cut healthcare costs, wrote a team led by Sebastian Altmann, MD, of University Medical Center Mainz in Germany.Example of (A-D) noncontrast transverse plane conventional MRI (c-MRI) and (E-H) deep learning-accelerated MRI scans in a 75-year-old male participant with acute left-...
Source: AuntMinnie.com Headlines - February 22, 2024 Category: Radiology Authors: Kate Madden Yee Tags: Artificial Intelligence Neuroradiology Source Type: news

Cerebrolysin for acute ischaemic stroke
Wednesday, February 21, 2024 (Source: Cochrane News and Events)
Source: Cochrane News and Events - February 21, 2024 Category: Information Technology Authors: Paolo Rosati Source Type: news

Sublingual Acute Stroke Neuroprotectant Dazzles in Phase III Trial
(MedPage Today) -- For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE-SL trial from China. The... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 20, 2024 Category: Cardiology Source Type: news

Serpent strikes, sapien sways: a rare case of bilateral cerebellar infarct following viper bite - Srinath KM, Sethi M, Madhu B, Prasad MC, Sangappa SB.
We report a posterior circulation infarct involving bilateral cerebellum and occipital lobe following Russell's viper bite in a previously healthy individual. A 50 years old healthy individual, soon after being... (Source: SafetyLit)
Source: SafetyLit - February 19, 2024 Category: International Medicine & Public Health Tags: Non-Human Animals and Insects Source Type: news

What are Some Causes of Acute Onset of Loss of Speech Abilities?
Discussion Acute mental status changes are worrisome in the least and scary at their worst. Seizures, cerebrovascular problems and central nervous system tumor swirl in professionals’ heads as they take in the history, physical examination and start to evaluate and manage the problem. Usually respiratory distress is recognized by family members and treatment is also sought. Another cause of loss of speech is selective (or elective) mutism (SM). The child does not speak at all or minimally. When speaking it is usually within a close group of individuals or in certain circumstances such as only speaking to a parent o...
Source: PediatricEducation.org - February 19, 2024 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

ASA: Endovascular Thrombectomy Beneficial for Large Ischemic Stroke
FRIDAY, Feb. 16, 2024 -- For patients with acute ischemic stroke and large cores, endovascular thrombectomy (EVT) improves clinical outcomes compared with medical management (MM), according to a study published online Feb. 7 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2024 Category: Pharmaceuticals Source Type: news

Acupuncture Linked to Lower Incidence of Ischemic Stroke in RA
FRIDAY, Feb. 16, 2024 -- For patients with rheumatoid arthritis (RA), the risk for ischemic stroke is lower for those receiving acupuncture, according to a study published online Feb. 13 in BMJ Open. Chia-Yu Huang, from Taichung Tzu Chi Hospital in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2024 Category: Pharmaceuticals Source Type: news

Sun Pharma scouting for innovative therapies to boost India business
Approved by the Indian drug regulator in May 2023, sovateltide can be administered within 24 hours for the treatment of ischemic stroke, almost five times more than the narrow time window of 4-5 hours offered by current treatment options like tissue plasminogen activator (TPA) called thrombolytic drugs that dissolve the clots that cause strokes. An ischemic stroke is a medical emergency that occurs when blood supply to part of a brain is blocked or reduced. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2024 Category: Pharmaceuticals Source Type: news